iih and glp 1 Beyond weight loss: a case study narrative review of the potential role of glucagon-like peptide-1 receptor agonists for the treatment of idiopathic intracranial hypertension - Paulo Idiopathic Intracranial Hypertension and the

No heart attacks, strokes, or cardiovascular deaths have been attributed to retatrutide in published trial data

E., Jenkins, V., Nottingham, K., Dickerson, B., Leonard, M., Ko, J., Lewis, M

Honestly, we've never seen anything like it

When THR- is stimulated by an agonist (e.g., resmetirom), it improves liver health by initiating a cascade of processes that are often dysregulated in patients with MASH and that are associated with disease progression and the development of hepatic fibrosis

These mechanisms improve glycemic control in type 2 diabetes and contribute to weight loss by prolonging satiety and reducing appetite